Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

AIMS: The Liraglutide Effect and Action in Diabetes 6 trial was an open-label trial comparing liraglutide with exenatide as an ‘add-on’ to metformin and/or sulphonylurea. METHODS: Patients with Type 2 diabetes were randomized to liraglutide 1.8 mg once daily or exenatide 10 μg twice daily for 26 wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, W E, Christiansen, J S, Hammer, M, Zychma, M J, Buse, J B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123703/
https://www.ncbi.nlm.nih.gov/pubmed/21388442
http://dx.doi.org/10.1111/j.1464-5491.2011.03276.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123703/
https://www.ncbi.nlm.nih.gov/pubmed/21388442
http://dx.doi.org/10.1111/j.1464-5491.2011.03276.x

Ejemplares similares